Statistical significance of human susceptibility loci after collapsing genotypes
Locus (mouse) . | Locus (human) . | All (231 cases, 256 controls) . | . | . | . | Males (187 cases, 189 controls) . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | χ2 . | P . | OR . | 95% CI . | χ2 . | P . | OR . | 95% CI . | ||||||
Ephx1 | EPHX1-exon3(1)a | 2.30 | 0.13 | 1.57 | 0.87–2.83 | 0.42 | 0.51 | 1.24 | 0.6–2.41 | ||||||
Ephx1 | EPHX1-exon4 | 0.21 | 0.64 | 1.13 | 0.68–1.86 | 0.03 | 0.85 | 1.05 | 0.59–1.85 | ||||||
Ephx2 | EPHX2 | 9.1 | 0.002 | 2.06 | 1.28–3.32 | 10.6 | 0.001 | 2.49 | 1.42–4.36 | ||||||
Gsta4 | GSTA4 | 0.95 | 0.33 | 0.84 | 0.58–1.20 | 4.52 | 0.03 | 1.55 | 1.03–2.35 | ||||||
Gstm1 | GSTM1 | 0.95 | 0.33 | 0.83 | 0.57–1.21 | 0.83 | 0.36 | 0.82 | 0.54–1.25 | ||||||
Gstt1 | GSTT1 | 0.38 | 0.53 | 0.88 | 0.59–1.31 | 0.02 | 0.88 | 0.96 | 0.62–1.50 |
Locus (mouse) . | Locus (human) . | All (231 cases, 256 controls) . | . | . | . | Males (187 cases, 189 controls) . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | χ2 . | P . | OR . | 95% CI . | χ2 . | P . | OR . | 95% CI . | ||||||
Ephx1 | EPHX1-exon3(1)a | 2.30 | 0.13 | 1.57 | 0.87–2.83 | 0.42 | 0.51 | 1.24 | 0.6–2.41 | ||||||
Ephx1 | EPHX1-exon4 | 0.21 | 0.64 | 1.13 | 0.68–1.86 | 0.03 | 0.85 | 1.05 | 0.59–1.85 | ||||||
Ephx2 | EPHX2 | 9.1 | 0.002 | 2.06 | 1.28–3.32 | 10.6 | 0.001 | 2.49 | 1.42–4.36 | ||||||
Gsta4 | GSTA4 | 0.95 | 0.33 | 0.84 | 0.58–1.20 | 4.52 | 0.03 | 1.55 | 1.03–2.35 | ||||||
Gstm1 | GSTM1 | 0.95 | 0.33 | 0.83 | 0.57–1.21 | 0.83 | 0.36 | 0.82 | 0.54–1.25 | ||||||
Gstt1 | GSTT1 | 0.38 | 0.53 | 0.88 | 0.59–1.31 | 0.02 | 0.88 | 0.96 | 0.62–1.50 |
Contrasting individuals with CC genotypes versus individuals with CT and TT genotypes.